|
Brett Bookser, Ph.D. is a principal research analyst at Drug Hunter. He received his Ph.D. in organic chemistry from the University of California, San Diego. Brett has extensive experience in drug discovery for diseases including cancer, infections, cystic fibrosis, CNS, metabolic, and cardiovascular disorders. He is known for optimizing compounds for therapeutic efficacy and tissue specificity. Brett's career includes roles as a medicinal chemistry consultant, associate director at Vir Biotechnology, principal scientist at ChemPartner, and senior scientist at Vertex Pharmaceuticals. He has also worked at Dart NeuroScience, Helicon Therapeutics, and Metabasis Therapeutics. At Drug Hunter, Brett provides curated reviews of small molecule drug discovery efforts, offering valuable insights to the community.
|
